CNS purchases FiberChoice(R) patents
The patents and patent applications cover CNS' existing product line of FiberChoice fiber supplements and will begin to expire in December 2016.
06/01/06 CNS, Inc., the Breathe Right(R) company, has announced the purchase of a portfolio of domestic and international patents and patents pending related to the FiberChoice(R) brand for approximately $8 million from Onesta Nutrition, Inc. As part of this transaction, CNS and Onesta Nutrition have cancelled their existing license agreement related to these patents. The transaction, which was completed January 4, 2006, was funded by CNS' existing cash balances, and is expected to be earnings neutral in the next fiscal year, ending March 31, 2007.
The patents and patent applications cover CNS' existing product line of FiberChoice fiber supplements and will begin to expire in December 2016.
Net sales of FiberChoice branded products through the first half of fiscal 2006 grew to $9.7 million, an increase of 86 percent compared to the prior-year period. FiberChoice is currently available in original Orange and Assorted Fruit Flavored chewable tablets, and Fiber Drops. In addition, CNS has announced it will begin shipping two new FiberChoice branded products to retailers in February 2006: FiberChoice plus Calcium(TM) chewable tablets; and FiberChoice Weight Management(TM) chewable tablets.
CNS, based in Minneapolis, designs and markets consumer health care products, including Breathe Right(R) nasal strips and FiberChoice(R) dietary fiber supplements. The company focuses on products that address important consumer needs within the aging well/self care market, including better breathing and digestive health.
